Literature DB >> 29175120

Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.

Mona Hussein El-Samahy1, A A Adly2, Yasmine Ibrahim Elhenawy1, E A Ismail3, Shaimaa Abdelmalik Pessar3, Mohamed El-Sayed Mowafy1, Mohammed Salah Saad1, Hossam Hassan Mohammed1.   

Abstract

BACKGROUND: Urinary microRNAs (miRNAs) play a role in the pathogenesis of chronic kidney disease (CKD). AIM: To identify the expression of urinary miR-377 and miR-216a in 50 children and adolescents with type 1 diabetes (T1DM) compared with 50 healthy controls and assess their relation to the degree of albuminuria, glycemic control and carotid intimal thickness (CIMT) as an index of atherosclerosis.
METHODS: Diabetic subjects were divided into normoalbuminuric and microalbuminuric groups according to urinary albumin creatinine ration (UACR). Urinary miRNAs were assessed using real time polymerase chain reaction. CIMT was measured using high resolution carotid ultrasound.
RESULTS: The expression of urinary miR-377 was significantly higher in patients with microalbumiuria (median, 3.8) compared with 2.65 and 0.98 in normoalbuminic patients and healthy controls, respectively (p<0.05). Urinary miR-216a was significantly lower in all patients with type 1 diabetes and the lowest levels were among the microalbumiuric group. Significant positive correlations were found between urinary miR-377 and HbA1C, UACR and CIMT while urinary miR-216a was negatively correlated to these variables.
CONCLUSIONS: Urinary miR-377 and miR-216a can be considered early biomarkers of nephropathy in pediatric type 1 diabetes. Their correlation with CIMT provides insights on the subclinical atherosclerotic process that occurs in diabetic nephropathy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; CIMT; Nephropathy; Type 1 diabetes; Urinary micorRNA

Mesh:

Substances:

Year:  2017        PMID: 29175120     DOI: 10.1016/j.jdiacomp.2017.10.014

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  12 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

2.  MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes.

Authors:  Shereen Abdelghaffar; Hassan Shora; Sahar Abdelatty; Fatma Elmougy; Reham El Sayed; Heba Abdelrahman; Hend Soliman; HebatAllah Algebaly; Sakinatalfouad Ahmed; Peter Alfy; Yasmine Elshiwy
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-13       Impact factor: 3.168

Review 3.  MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease.

Authors:  Linicene Rosa do Nascimento; Caroline Pereira Domingueti
Journal:  J Bras Nefrol       Date:  2019-02-07

Review 4.  The Interplay Between Diet and the Epigenome in the Pathogenesis of Type-1 Diabetes.

Authors:  Amira Kohil; Maha Al-Asmakh; Mashael Al-Shafai; Annalisa Terranegra
Journal:  Front Nutr       Date:  2021-01-28

5.  Demethylated miR-216a Regulates High Mobility Group Box 3 Promoting Growth of Esophageal Cancer Cells Through Wnt/β-Catenin Pathway.

Authors:  Cheng-Xi Sun; Feng Zhu; Lei Qi
Journal:  Front Oncol       Date:  2021-03-23       Impact factor: 6.244

6.  miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus.

Authors:  Zhaozhao Hua; Dana Li; Anqin Wu; Ting Cao; Shi Luo
Journal:  Open Med (Wars)       Date:  2021-03-25

7.  Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy.

Authors:  Rafal Czapiewski; Dzmitry G Batrakou; Jose I de Las Heras; Roderick N Carter; Aishwarya Sivakumar; Magdalena Sliwinska; Charles R Dixon; Shaun Webb; Giovanna Lattanzi; Nicholas M Morton; Eric C Schirmer
Journal:  Nat Commun       Date:  2022-01-13       Impact factor: 17.694

Review 8.  Modeling epigenetic modifications in renal development and disease with organoids and genome editing.

Authors:  Carmen Hurtado Del Pozo; Elena Garreta; Juan Carlos Izpisúa Belmonte; Nuria Montserrat
Journal:  Dis Model Mech       Date:  2018-11-20       Impact factor: 5.758

Review 9.  Role of sirtuin-1 in diabetic nephropathy.

Authors:  Wanning Wang; Weixia Sun; Yanli Cheng; Zhonggao Xu; Lu Cai
Journal:  J Mol Med (Berl)       Date:  2019-02-01       Impact factor: 4.599

10.  MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2.

Authors:  Haijun Wang; Zheng Wei; Hulun Li; Yinghui Guan; Zhiyang Han; Hengzhen Wang; Bing Liu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.